Medicaid Generic Drug Price Fairness Act of 2015
Official title: A bill to amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the p… Show full official titleShow less
Official title: A bill to amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Medicaid Generic Drug Price Fairness Act of 2015
This bill amends title XIX (Medicaid) of the Social Security Act to increase the amount of rebate with respect to each generic drug in the manner that the rebate for a dosage form and strength of a single source drug or an innovator multiple source drug is increased, except as provided in special application rules, including a special rule for certain noninnovator multiple source drugs.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1364: Medicaid Generic Drug Price Fairness Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-S-1364/
"S. 1364: Medicaid Generic Drug Price Fairness Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-S-1364/.
S. 1364, 114th Cong. (2026), https://openamerica.io/bill/114-S-1364/.
[S. 1364: Medicaid Generic Drug Price Fairness Act of 2015](https://openamerica.io/bill/114-S-1364/)